Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Said M. Sebti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-5803-0662; OpenAlex author ID A5044739463. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer. Last author DOI 10.1016/j.ejca.2026.116255↗
  2. Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived Tumors. Last author DOI 10.1158/2767-9764.crc-23-0222↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vignesh Vudatha · 2 shared papers, 2023–2026 · strength 0.46
  2. Aslamuzzaman Kazi · 2 shared papers, 2023–2026 · strength 0.46
  3. Deblina Ghosh · 1 shared paper, 2026 · strength 0.32
  4. Christine A. Iacobuzio–Donahue · 1 shared paper, 2026 · strength 0.32
  5. Patrick W. Underwood · 1 shared paper, 2023 · strength 0.14
  6. Jason B. Fleming · 1 shared paper, 2023 · strength 0.14
  7. Jose Gilberto Trevino · 1 shared paper, 2023 · strength 0.14
  8. Perry Kennedy · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.